FITC-labeled Drisapersen (sodium)
Product Sizes
1 mg
£ POA
HY-150237-1MG
5 mg
£ POA
HY-150237-5MG
10 mg
£ POA
HY-150237-10MG
About this Product
- SKU:
- HY-150237
- Extra Details:
- FITC-labeled Drisapersen (sodium) is Drisapersen labeled with FITC. Drisapersen; a antisense oligonucleotide; induces exon 51 skipping during dystrophin pre-mRNA splicing and allows synthesis of partially functional dystrophin in Duchenne muscular dystrophy (DMD) patients with amenable mutations.
- Molecular Weight:
- 7962.60
- Purity:
- 92.99
- References:
- [1]Flanigan KM, Voit T, Rosales XQ, et al. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial. Neuromuscul Disord. 2014;24(1):16-24.|[2]Voit T, Topaloglu H, Straub V, et al. Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study. Lancet Neurol. 2014;13(10):987-996.
- Research Area:
- Others
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C (Powder; sealed storage; away from moisture)
- Type:
- Molecular Biology Reagents: Nucleic Acids
- Pathway:
- Cell Cycle/DNA Damage;Cytoskeleton
